We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+37.69%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$7.48B
AUM Growth
+$1.44B
Cap. Flow
-$77.6M
Cap. Flow %
-1.04%
Top 10 Hldgs %
23.83%
Holding
336
New
58
Increased
161
Reduced
69
Closed
35

Top Buys

Rank Stock Value
1
AVLN
Avalyn Pharma
AVLN
+$39.7M
2
CDNS icon
Cadence Design Systems
CDNS
+$29.6M
3
RELY icon
Remitly
RELY
+$27.3M
4
DELL icon
Dell
DELL
+$25.5M
5
FITB
Fifth Third Bancorp
FITB
+$25.3M

Top Sells

Rank Stock Value
1
XMTR icon
Xometry
XMTR
+$57.8M
2
PLD icon
Prologis
PLD
+$56.1M
3
GH icon
Guardant Health
GH
+$44M
4
AXSM icon
Axsome Therapeutics
AXSM
+$44M
5
GLBE icon
Global E Online
GLBE
+$37.6M

Sector Composition

Rank Sector Weight
1 Healthcare 36.37%
2 Technology 22.57%
3 Industrials 20.48%
4 Energy 5.51%
5 Utilities 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBIO icon
76
BridgeBio Pharma
BBIO
$15B
$32.6M 0.44%
437,130
– –
ROL icon
77
Rollins
ROL
$17.5B
$32.1M 0.43%
767,984
+14,485
+2% +$740K
HLI icon
78
Houlihan Lokey
HLI
$9.3B
$32M 0.43%
239,140
+3,004
+1% +$443K
OVID icon
79
Ovid Therapeutics
OVID
$547M
$31.8M 0.42%
11,812,241
+1,895,330
+19% +$4.89M
NRIX icon
80
Nurix Therapeutics
NRIX
$2.72B
$31.5M 0.42%
1,297,893
– –
VRT icon
81
Vertiv
VRT
$99B
$30.8M 0.41%
92,404
-2,606
-3% -$827K
COHR icon
82
Coherent
COHR
$54.7B
$30.6M 0.41%
77,487
+40,466
+109% +$14.3M
FITB
83
Fifth Third Bancorp
FITB
$49.5B
$30.5M 0.41%
539,040
+499,580
+1,266% +$25.3M
ARWR icon
84
Arrowhead Research
ARWR
$12B
$30.2M 0.4%
370,000
– –
RELY icon
85
Remitly
RELY
$5.62B
$29.9M 0.4%
+1,332,003
New +$27.3M
MSCI icon
86
MSCI
MSCI
$41.5B
$29.4M 0.39%
52,607
+1,539
+3% +$898K
HBAN icon
87
Huntington Bancshares
HBAN
$34.2B
$29.2M 0.39%
1,641,712
-891,790
-35% -$14.7M
IRON icon
88
Disc Medicine
IRON
$3.07B
$28.9M 0.39%
395,651
+79
+0% +$5.43K
ULS icon
89
UL Solutions
ULS
$15B
$28.6M 0.38%
281,062
+13,288
+5% +$1.26M
ROK icon
90
Rockwell Automation
ROK
$47.8B
$27.9M 0.37%
56,458
+446
+0.8% +$194K
CHWY icon
91
Chewy
CHWY
$9.52B
$27.8M 0.37%
1,413,874
+1,584
+0.1% +$36K
SNX icon
92
TD Synnex
SNX
$20.3B
$27M 0.36%
+100,983
New +$24.3M
CGON icon
93
CG Oncology
CGON
$6.59B
$26.3M 0.35%
369,839
-146
-0% -$9.54K
BKR icon
94
Baker Hughes
BKR
$62B
$25.6M 0.34%
459,110
+21,093
+5% +$1.33M
WCN
95
Waste Connections
WCN
$41.7B
$25.4M 0.34%
152,351
-157,576
-51% -$24.9M
ISRG icon
96
Intuitive Surgical
ISRG
$132B
$24.1M 0.32%
60,634
+692
+1% +$302K
SHW icon
97
Sherwin-Williams
SHW
$83.7B
$24.1M 0.32%
70,111
-1,013
-1% -$324K
AMLX icon
98
Amylyx Pharmaceuticals
AMLX
$3.87B
$23.8M 0.32%
1,327,536
-186,422
-12% -$2.88M
IEX icon
99
IDEX
IEX
$17B
$23.5M 0.31%
103,503
+2,610
+3% +$552K
ORKA
100
Oruka Therapeutics
ORKA
$6.03B
$22.8M 0.31%
+240,000
New +$16M
2 3
4
5 6

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Eventide Asset Management held 336 positions worth $7.48B, up 24% from $6.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q2 2026 filing shows 58 new, 161 increased, 69 reduced and 35 closed positions. Its largest new stake was Avalyn Pharma: 1,375,486 shares worth $45.3M. The largest sale was Xometry, an estimated $57.8M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q2 2026 buy was Avalyn Pharma: 1,375,486 shares worth $45.3M.
  • Eventide Asset Management added most to Cadence Design Systems in Q2 2026, an estimated $29.6M increase.
  • Eventide Asset Management's biggest Q2 2026 reduction was Xometry, cutting an estimated $57.8M.
  • Eventide Asset Management fully exited Prologis in Q2 2026, selling an estimated $56.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $7.48B portfolio in Q2 2026.
  • Eventide Asset Management opened 58 new positions and closed 35 in Q2 2026.
  • Eventide Asset Management's portfolio value rose 24% quarter-over-quarter to $7.48B.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.